4th Annual Mountain West
Biomedical Engineering Conference
September 5-6, 2008
Abstract Details
Presented By: | Blauer, Joshua |
Affiliated with: | University of Utah, Biomedical Engineering |
Authors: | Robert S. Oakes, Nathan M. Burgon, Christopher J. McGann MD, Troy J. Badger MD, Sathya Vijayakumar MS, Eugene G. Kholmovski PhD, Edward V.R. DiBella PhD, Nassir F. Marrouche MD, Rob S. MacLeod PhD |
From: | Biomedical Engineering, Scientific Computing and Imaging Institute, Division of Cardiology, Utah Center for Advanced Imaging Research |
Title
Abstract
Background. Delayed enhancement MRI (DE-MRI) allows visualization of post-procedure scarring in atrial fibrillation (AF) patients following pulmonary vein isolation (PVI) by radiofrequency ablation. We report on a method for quantification of atrial scarring in DE-MRI using dynamic thresholding.
Methods. Patients undergoing PVI were imaged 3 months post-procedure using 3D inversion recovery, navigated, gradient echo DE-MRI. Left atrial (LA) endocardial and epicardial contours were traced using custom software written in MATLAB. To differentiate between normal and enhanced regions we assumed Gaussian distributions of pixel intensities. A histogram of all LA pixel intensities was used to determine the mean and standard deviation (SD) of normal intensities for each slice of MRI data. Any pixel intensity greater than 3 SD’s above the mean was labeled as hyper-enhanced and the set of all such pixels served to localize and quantify regions of post-procedure scar throughout the entire LA.
Results. The left-hand images below show a single slice of MRI data with atrial contours (upper panel) and LA hyper-enhancement (predicted scarring) marked with black pixels (lower panel). The right-hand images show two projections of the LA data with predicted scarred regions colored in blue. The hyper-enhanced regions were cohesive and consistently located at the pulmonary vein ostia and posterior wall.
Conclusion. This form of dynamic thresholding provides a reproducible means for quantifying hyper-enhancement and thus scar formation in the LA of AF patients post PVI.